|
1
|
Bartek J, Bartkova J and Lukas J: DNA
damage signalling guards against activated oncogenes and tumour
progression. Oncogene. 26:7773–7779. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Halazonetis TD, Gorgoulis VG and Bartek J:
An oncogene-induced DNA damage model for cancer development.
Science. 319:1352–1355. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jackson SP and Bartek J: The DNA-damage
response in human biology and disease. Nature. 461:1071–1078. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shimada M and Nakanishi M: Response to DNA
damage: Why do we need to focus on protein phosphatases? Front
Oncol. 3:82013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang ZP, Tian Y and Lin J: Role of
wild-type p53-induced phosphatase 1 in cancer. Oncol Lett.
14:3893–3898. 2107. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fiscella M, Zhang HL, Fan S, Sakaguchi K,
Shen S, Mercer EW, Vande Woude GF, O'Connor MP and Appella E: Wip1,
a novel human protein phosphatase that is induced in response to
ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci
USA. 94:6048–6053. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chew J, Biswas S, Shreeram S, Humaidi M,
Wong ET, Dhillion MK, Teo H, Hazra A, Fang CC, López-Collazo E, et
al: WIP1 phosphatase is a negative regulator of NF-kappaB
signalling. Nat Cell Biol. 11:659–666. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Le Guezennec X and Bulavin DV: WIP1
phosphatase at the crossroads of cancer and aging. Trends Biochem
Sci. 35:109–114. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lowe J, Cha H, Lee MO, Mazur SJ, Appella E
and Fornace AJ Jr: Regulation of the Wip1 phosphatase and its
effects on the stress response. Front Biosci (Landmark Ed).
17:1480–1498. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao M, Zhang H, Zhu G, Liang J, Chen N,
Yang Y, Liang X, Cai H and Liu W: Association between
overexpression of Wip1 and prognosis of patients with non-small
cell lung cancer. Oncol Lett. 11:2365–2370. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goloudina AR, Kochetkova EY, Pospelova TV
and Demidov ON: Wip1 phosphatase: Between p53 and MAPK kinases
pathways. Oncotarget. 7:31563–31571. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yin S, Wang P, Yang L, Liu Y, Wang Y, Liu
M, Qi Z, Meng J, Shi TY, Yang G and Zang R: Wip1 suppresses ovarian
cancer metastasis through the ATM/AKT/Snail mediated signaling.
Oncotarget. 7:29359–29370. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pechackova S, Burdova K, Benada J,
Kleiblova P, Jenikova G and Macurek L: Inhibition of WIP1
phosphatase sensitizes breast cancer cells to genotoxic stress and
to MDM2 antagonist nutlin-3. Oncotarget. 7:14458–14475. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Macurek L, Benada J, Müllers E, Halim VA,
Krejčíková K, Burdová K, Pecháčková S, Hodný Z, Lindqvist A, Medema
RH and Bartek J: Downregulation of Wip1 phosphatase modulates the
cellular threshold of DNA damage signaling in mitosis. Cell Cycle.
12:251–262. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pecháčková S, Burdová K and Macurek L:
WIP1 phosphatase as pharmacological target in cancer therapy. J Mol
Med (Berl). 95:589–599. 2017. View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eren MK and Tabor V: The role of hypoxia
inducible factor-1 alpha in bypassing oncogene-induced senescence.
PLoS One. 9:e1010642014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Drexler HG, Fombonne S, Matsuo Y, Hu ZB,
Hamaguchi H and Uphoff CC: p53 alterations in human
leukemia-lymphoma cell lines: In vitro artifact or prerequisite for
cell immortalization? Leukemia. 14:198–206. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bulavin DV, Demidov ON, Saito S,
Kauraniemi P, Phillips C, Amundson SA, Ambrosino C, Sauter G,
Nebreda AR, Anderson CW, et al: Amplification of PPM1D in human
tumors abrogates p53 tumor-suppressor activity. Nat Genet.
31:210–215. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martin AC, Facchiano AM, Cuff AL,
Hernandez-Boussard T, Olivier M, Hainaut P and Thornton JM:
Integrating mutation data and structural analysis of the TP53
tumor-suppressor protein. Human Mutat. 19:149–164. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bond GL, Hu W and Levine AJ: MDM2 is a
central node in the p53 pathway: 12 years and counting. Curr Cancer
Drug Targets. 5:3–8. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu X, Ma O, Nguyen TA, Jones SN, Oren M
and Donehower LA: The Wip1 Phosphatase acts as a gatekeeper in the
p53-Mdm2 autoregulatory loop. Cancer Cell. 12:342–54. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Goloudina AR, Tanoue K, Hammann A,
Fourmaux E, Le Guezennec X, Bulavin DV, Mazur SJ, Appella E,
Garrido C and Demidov ON: Wip1 promotes RUNX2-dependent apoptosis
in p53-negative tumors and protects normal tissues during treatment
with anticancer agents. Proc Natl Acad Sci USA. 109:E68–E75. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu YH, Zhang CW, Lu L, Demidov ON, Sun L,
Yang L, Bulavin DV and Xiao ZC: Wip1 regulates the generation of
new neural cells in the adult olfactory bulb through p53-dependent
cell cycle control. Stem Cells. 27:1433–1442. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xia ZS, Wu D, Zhong W, Lu XJ, Yu T and
Chen QK: Wip1 gene silencing enhances the chemosensitivity of human
colon cancer cells. Oncol Lett. 14:1875–1883. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Burma S, Chen BP, Murphy M, Kurimasa A and
Chen DJ: ATM phosphorylates histone H2AX in response to DNA
double-strand breaks. J Biol Chem. 276:42462–42467. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mukherjee B, Kessinger C, Kobayashi J,
Chen BP, Chen DJ, Chatterjee A and Burma S: DNA-PK phosphorylates
histone H2AX during apoptotic DNA fragmentation in mammalian cells.
DNA Repair. 5:575–590. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang H, Wang M, Wang H, Böcker W and
Iliakis G: Complex H2AX phosphorylation patterns by multiple
kinases including ATM and DNA-PK in human cells exposed to ionizing
radiation and treated with kinase inhibitors. J Cell Physiol.
202:492–502. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pilié PG, Tang C, Mills GB and Yap TA:
State-of-the-art strategies for targeting the DNA damage response
in cancer. Nat Rev Clin Oncol. 16:81–104. 2019. View Article : Google Scholar
|
|
30
|
Kilic M and Schmitt CA: Exploiting drug
induced senescence in transgenic mouse models. Beyond Apoptosis:
Cellular Outcomes of Cancer Therapy. Roninson IB, Brown JM and
Bredesen DE: Informa Health Care Publication; pp. 273–295. 2008,
View Article : Google Scholar
|
|
31
|
Crescenzi E, Raia Z, Pacifico F, Mellone
S, Moscato F, Palumbo G and Leonardi A: Down-regulation of
wild-type p53-induced phosphatase 1 (Wip1) plays a critical role in
regulating several p53-dependent functions in premature senescent
tumor cells. J Biol Chem. 288:16212–24. 2013. View Article : Google Scholar : PubMed/NCBI
|
